Terms ending in 2035

The Institut Pasteur

Every in-force patent on The Institut Pasteur's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.

Patent	Title	Holder	Status	Expires	Confidence
US 10,087,245	Camelid Single-Domain Antibody Directed Against Phosphorylated Tau Proteins and Methods for Producing Conjugates Thereof F. Hoffmann-La Roche AG, Institut Pasteur, Commissariat a l'Energie Atomique et aux Energies Alternatives and Centre National de la Recherche Scientifique (CNRS) In force Term ends Jan 28, 2035 · High confidence	F. Hoffmann-La Roche AG, Institut Pasteur, Commissariat a l'Energie Atomique et aux Energies Alternatives and Centre National de la Recherche Scientifique (CNRS)	In force	Term ends Jan 28, 2035	High confidence
US 10,538,582	Camelid Single-Domain Antibody Directed Against Phosphorylated Tau Proteins and Methods for Producing Conjugates Thereof Centre National de la Recherche Scientifique (CNRS) In force Term ends Jan 28, 2035 · High confidence	Centre National de la Recherche Scientifique (CNRS)	In force	Term ends Jan 28, 2035	High confidence
US 11,124,563	Camelid Single-Domain Antibody Directed Against Phosphorylated Tau Proteins and Methods for Producing Conjugates Thereof Centre National de la Recherche Scientifique (CNRS) In force Ends no later than Jan 30, 2035 · Medium confidence	Centre National de la Recherche Scientifique (CNRS)	In force	Ends no later than Jan 30, 2035	Medium confidence
US 11,918,613	Bacteriophage Therapy Institut Pasteur In force Term ends Mar 20, 2035 · High confidence	Institut Pasteur	In force	Term ends Mar 20, 2035	High confidence
US 11,732,312	Molecular Marker of Plasmodium Falciparum Artemisinin Resistance Centre National de la Recherche Scientifique In force Term ends Mar 29, 2035 · High confidence	Centre National de la Recherche Scientifique	In force	Term ends Mar 29, 2035	High confidence
US 10,010,597	Recombinant Mycobacterium Bovis BCG Expressing Antigens of the Mycobacterium Marinum ESX-1 Secretion System Institut Pasteur In force Term ends Jun 3, 2035 · High confidence	Institut Pasteur	In force	Term ends Jun 3, 2035	High confidence
US 10,463,713	Use of AAC-11 Inhibitors for the Treatment of Viral Infection Université Paris Cité In force Term ends Jun 21, 2035 · High confidence	Université Paris Cité	In force	Term ends Jun 21, 2035	High confidence
US 10,316,066	A Dengue Virus Chimeric Polyepitope Composed of Fragments of Non-Structural Proteins and Its Use in an Immunogenic Composition Against Dengue Virus Infection Institut Pasteur and Institut Pasteur du Cambodge In force Term ends Jun 22, 2035 · High confidence	Institut Pasteur and Institut Pasteur du Cambodge	In force	Term ends Jun 22, 2035	High confidence
US 10,808,284	Broad Range Gene and Genotype Papillomavirus Transcriptome as a Biomarker of Papillomavirus-Associated Cancer Stages Institut Pasteur, Ecole Nationale Veterinaire d'Alfort, Pathoquest and L'Assistance Publique - Hopitaux de Paris In force Term ends Jul 7, 2035 · High confidence	Institut Pasteur, Ecole Nationale Veterinaire d'Alfort, Pathoquest and L'Assistance Publique - Hopitaux de Paris	In force	Term ends Jul 7, 2035	High confidence
US 11,040,078	Bacteriophage Therapy Institut Pasteur In force Term ends Jul 8, 2035 · High confidence	Institut Pasteur	In force	Term ends Jul 8, 2035	High confidence
11 more term ends in 2035 · Pro

10 of 21 patents shown. Soonest term end first, then patent number.

Pro members see all 21.

Upgrade to Pro

17 of these are in force and held by The Institut Pasteur.

Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.